This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
Since our last update, “Euronext Continues To Deleverage,” the company stock price declined by an additional 10% (OTCPK:EUXTF). Today, we are not providing a...
This article provides an in-depth technical analysis of The Coca-Cola Company (NYSE:KO), a global behemoth in the beverage industry. The objective is to forecast...
By Jeffrey Schulze, CFA, Investment Strategist, ClearBridge Investments In this episode, we speak with Jeff Schulze, head of economic and market research at ClearBridge...
Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...